Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiation Plus Chemotherapy Versus Radiation Alone in High Risk Endometrial Carcinoma
NCT00005583Phase 3Completed
- Sponsor
- Nordic Society of Gynaecological Oncology Clinical Trial Unit
- Start
- Jan 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 11
01
Overview
A Phase 3 trial of cisplatin, doxorubicin, epirubicin in endometrial cancer (EC), sponsored by Nordic Society of Gynaecological Oncology Clinical Trial Unit. Started Jan 2000; status: completed.
02
Drugs
cisplatindoxorubicinepirubicin
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00005583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005583.